News tagged adverse-drug-events
DEA Guidance Regarding Information Pharmacists May Provide on CS II Prescriptions
Recognizing that pharmacists are sometimes presented with prescriptions for Schedule II controlled substances that are missing information required by law, Drug Enforcement Administration provides guidance for pharmacists regarding allowed changes or additions to such prescriptions.
Read More →Nominations for 2014 NABP Annual Awards Now Being Accepted
NABP invites you to nominate a colleague or board of pharmacy for a 2014 NABP award.
Read More →FDA Provides New Information About Lack of Sterility Assurance for Drugs Dispensed by The Compounding Shop
Food and Drug Administration (FDA) is warning patients and health care providers that budesonide solution (for nasal irrigation), dispensed by The Compounding Shop of St Petersburg, FL, may be contaminated and should not be used or administered to patients.
Read More →FDA Requires Changes to Fentanyl Pain Patch Warnings
To reduce the risk of accidental exposure, FDA has announced new requirements that change the appearance of fentanyl pain patch warnings to make them more visible.
Read More →FDA Observes 20 Years of Supporting Medication Safety Through MedWatch Program
For 20 years, FDA’s MedWatch program has supported medication safety efforts by providing a means for health care providers and consumers to report safety information regarding FDA-regulated products.
Fentanyl Patches Should Be Stored and Disposed of Properly to Avoid Accidental Poisonings in Children
Fentanyl patches should be securely stored out of the sight and reach of children and disposed of properly, advises Food and Drug Administration (FDA).
FDA Issues New Guidelines for Sleep Aids Containing Zolpidem
FDA has issued new dosing recommendations for sleep aids containing zolpidem.
Emergency Room Pharmacists Help Reduce Medication Errors
A recent study conducted by Winchester Medical Center in Winchester, VA, shows that involving pharmacists and pharmacy technicians in the hospital admissions process reduced medication errors.
Rare Cases of Burns Associated with OTC Topical Muscle and Joint Pain Relievers, FDA Warns
FDA alerts the public that certain over-the-counter (OTC) products that are applied to the skin for the relief of mild muscle and joint pain have been reported to cause rare cases of serious skin injuries. These OTC topical muscle and...
Read More →Severe Health Risks Associated With Use of Reumofan Supplement Products, FDA Warns
Food and Drug Administration (FDA) warns that consumers should not use Reumofan Plus products due to serious health risks related to the presence of prescription drug ingredients not listed on product labels. In a news release, FDA explains that the...
Read More →Reumofan Plus Recalled, FDA Notifies Consumers Using the Product to Consult a Health Care Provider
FDA issued a safety alert notifying consumers about the recall of Reumofan Plus, a product marketed as a natural dietary supplement for pain relief and other serious conditions. The product contains several active pharmaceutical ingredients not listed on the label...
Read More →Ohio News: Accidental Drug Poisonings in Ohio
Published in the November 2009 Ohio State Board of Pharmacy Newsletter The Ohio Department of Health (ODH) compiles statistics on many different health-related topics every year and tries to monitor trends so that action can be taken when needed. Just...
Read More →